Perkins Coie Trust Company’s Idexx Laboratories IDXX Stock Holding History

Perkins Coie Trust Company’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13	Closed	-$5.68K	–	446
2023 Q3	$5.68K	Buy	+13	New	+$6.48K	﹤0.01%	272
2021 Q4	–	Sell	-5	Closed	-$3K	–	250
2021 Q3	$3K	Hold	5	–	–	﹤0.01%	241
2021 Q2	$3K	Buy	+5	New	+$2.76K	﹤0.01%	253

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Perkins Coie Trust Company's IDXX Position: Q4 2023 in Review

Perkins Coie Trust Company sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 13 shares — an estimated $5.68K sold.

Perkins Coie Trust Company first reported a position in IDXX in Q2 2021 and held it in 3 quarters. The position peaked at $5.68K in Q3 2023. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

Perkins Coie Trust Company reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
Perkins Coie Trust Company sold 13 Idexx Laboratories shares in Q4 2023, an estimated $5.68K.
Perkins Coie Trust Company first reported a position in Idexx Laboratories in Q2 2021 and held it in 3 quarters.
Perkins Coie Trust Company's Idexx Laboratories position peaked at $5.68K in Q3 2023.
1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Perkins Coie Trust Company's 13F filing for Q4 2023, filed 9 Jan 2024.